Concepedia

Eliza Bollinger

EB

8

Publications

366

Citations

8

H-Index

2017

Active since

Affiliations

Pfizer (United States)(Current)

Eliza Bollinger is an author at Pfizer (United States) specializing in atherosclerosis, vascular biology, and oxidative stress.

Top concepts

Publications per year

2017–2025

8

Publications

8

Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models

Ryan M. Esquejo, Christopher T. Salatto, Jake Delmore et al. · EBioMedicine · 2018 · 146 citations · Full text

Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy

Christopher T. Salatto, Russell Miller, Kimberly O. Cameron et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 79 citations · Full text

Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition

Rachel J. Roth Flach, Chunyan Su, Eliza Bollinger et al. · PLoS ONE · 2019 · 43 citations · Full text

, , +16

BDK inhibition acts as a catabolic switch to mimic fasting and improve metabolism in mice

Eliza Bollinger, Matthew Peloquin, Jenna Libera et al. · Molecular Metabolism · 2022 · 36 citations · Full text

Small molecule branched-chain ketoacid dehydrogenase kinase (BDK) inhibitors with opposing effects on BDK protein levels

Rachel J. Roth Flach, Eliza Bollinger, Allan R. Reyes et al. · Nature Communications · 2023 · 27 citations · Full text

Rows per page

1–5 of 8